SCRI

2026 -Post ASCO Media Coverage

Issue link: https://uberflip.scri.com/i/1545364

Contents of this Issue

Navigation

Page 7 of 7

0611/26SCR019-18/R6RGB Media Highlights From the 2026 ASCO® Annual Meeting 8 David Spigel, MD SCRI David Waterhouse, MD SCRI at OHC I The US Oncology Network Media Outlet Date Article / Coverage Oncology News Central 6/1/26 Ivonescimab Shows Survival Improvement in Advanced Squamous NSCLC, With Caveats Pharmaphorum 5/31/26 ASCO26: Ivonescimab Improves Survival in NSCLC Reuters 5/31/26 Akeso Lung Cancer Drug Helps Patients Live 15% Longer Than Immunotherapy in China Trial Scrip 6/1/26 ASCO: Lilly Details Game-Changing Retevmo Data in Lung Cancer Targeted Oncology 6/1/26 Ivonescimab Combo Shows Superior Overall Survival in Advanced Squamous NSCLC Targeted Oncology 5/31/26 Adjuvant Selpercatinib Significantly Extends EFS in RET Fusion–Positive NSCLC Media Outlet Date Article / Coverage Cancer Network 6/1/26 AI Tool Shows Prostate Cancer Genetic Testing Feasibility in Community Care Cancer Network 6/4/26 AI-Based Prostate Cancer Guideline Interpretation Shows Scaling Feasibility

Articles in this issue

Links on this page

view archives of SCRI - 2026 -Post ASCO Media Coverage